Opinion
Opinion: Turkey’s Scientists Under Pressure
Opinion: Turkey’s Scientists Under Pressure
Elaine Howard Ecklund, David R. Johnson, Kirstin R.W. Matthews | Sep 14, 2016
The embattled country’s research enterprise is at risk following a failed coup, designed to overthrow a regime that shows continued hostility toward science.
Opinion: Retool Biomedical PhD Admissions
Opinion: Retool Biomedical PhD Admissions
Viviane Callier and Gary McDowell | Aug 30, 2016
It is unethical to admit increasing numbers of students to graduate programs without considering the realities of the job market.
Opinion: GMOs Are Not “Frankenfoods”
Opinion: GMOs Are Not “Frankenfoods”
Dov Greenbaum, Mark Gerstein | Aug 30, 2016
It behooves the scientific community to reflect on the public’s “Franken-” characterization of genetically modified foods.
Opinion: A Baseball Analogy
Opinion: A Baseball Analogy
Dean Tantin | Jul 26, 2016
Stiff competition under the current biomedical publishing model prevents important work from reaching a wider community in a timely manner. 
Opinion: Two Steps Toward Establishing Priority of Discovery
Opinion: Two Steps Toward Establishing Priority of Discovery
Ronald Vale and Anthony Hyman | Jul 19, 2016
Establishing priority of a new finding is best achieved through a combination of a rapid, scientist-controlled disclosure followed by subsequent validation, through journal-based peer review and other mechanisms.
Opinion: Target the Vector
Opinion: Target the Vector
Mirco Junker | Jun 28, 2016
Officials’ increased emphasis on mosquito control could benefit public health efforts beyond the ongoing Zika outbreak. 
Opinion: The Zika Effect
Opinion: The Zika Effect
Vincent Racaniello | May 27, 2016
Three reasons why virologists are flocking to study this emerging virus
Opinion: Reimagining the Paper
Opinion: Reimagining the Paper
Ahmed Alkhateeb | May 2, 2016
Breaking down lengthy, narrative-driven biomedical articles into brief reports on singular observations or experiments could increase reproducibility and accessibility in the literature.
Opinion: Share Data for All Diseases
Opinion: Share Data for All Diseases
Elizabeth Marincola | Apr 28, 2016
Along with his recent $250 million donation to cancer research, Silicon Valley entrepreneur Sean Parker emphasized the importance of data sharing.
Book Review: <em>Personal Trials</em>
Book Review: Personal Trials
Arthur L. Caplan | Mar 22, 2016
At first blush, do-it-yourself clinical trials seem pointless and reckless. But a deeper truth pervades the research and the patients who drive it forward.